Integrat Respir Med
Volume 1, 2020
Topical Issue - Integrative Respiratory Medicine for COVID-19
Article Number 3
Number of page(s) 9
Published online 18 December 2020
  • Howard-Anderson J, Webster A, Goyal A, et al. (2020), COVID-19 or common coronavirus? A cautionary tale in advanced diagnostics. Diagnosis (Berl) 7, 4, 345–346. [Google Scholar]
  • Moraleda C, Serna-Pascual M, Soriano-Arandes A, et al. (2020), Multi-inflammatory syndrome in children related to SARS-CoV-2 in Spain. Clin Infect Dis. [Google Scholar]
  • González-Castro A, Escudero-Acha P, Arnaiz F, et al. (2020), High-flow oxygen therapy with spontaneous breathing prono position in SARS-CoV-2 pneumonia. Rev Esp Anestesiol Reanim 67, 9, 529–530. [CrossRef] [PubMed] [Google Scholar]
  • Wellinghausen N, Plonné D, Voss M, et al. (2020), SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons. J Clin Virol 130, 104542. [CrossRef] [PubMed] [Google Scholar]
  • Riva L, Yuan S, Yin X, et al. (2020), Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature 586, 113–119. [CrossRef] [PubMed] [Google Scholar]
  • Sindhuja K, Lomi N, Asif MI, et al. (2020), Clinical profile and prevalence of conjunctivitis in mild COVID-19 patients in a tertiary care COVID-19 hospital: A retrospective cross-sectional study. Indian J Ophthalmol 68, 8, 1546–1550. [CrossRef] [PubMed] [Google Scholar]
  • Waqas Khan HM, Parikh N, Megala SM, et al. (2020), Unusual early recovery of a critical COVID-19 patient after administration of intravenous vitamin C. T Am J Case Rep 21, e925521. [Google Scholar]
  • Wang C-H, Zhong Y, Zhang Y, et al. (2016), A network analysis of the Chinese medicine Lianhua-Qingwen formula to identify its main effective components. Mol Biosyst 12, 2, 606–613. [Google Scholar]
  • Gao D, Niu M, Wei S-Z, et al. (2020), Identification of a pharmacological biomarker for the bioassay-based quality control of a thirteen-component TCM Formula (Lianhua Qingwen) Used in treating influenza A virus (H1N1) infection. Front Pharmacol 11, 746. [CrossRef] [PubMed] [Google Scholar]
  • Wang C-H, Zhong Y, Zhang Y, et al. (2016), A network analysis of the Chinese medicine Lianhua-Qingwen formula to identify its main effective components. Mol Biosyst 12, 2, 606–613. [Google Scholar]
  • Yang C, Wang Y, He J, et al. (2020), Lianhua-Qingwen Displays antiviral and anti-inflammatory activity and synergistic effects with oseltamivir against influenza B virus infection in the mouse model. Evid Based Complement Alternat Med 2020, 3196375. [Google Scholar]
  • Lin L-X, Li S-X, Zheng F-Y (2014), Application of in vitro bionic digestion and biomembrane extraction for metal speciation analysis, bioavailability and risk assessment in Lianhua Qingwen capsule. China J Chin Mater Med 39, 12, 2330–2335. [Google Scholar]
  • Dang J-Z, Zhu G-Y, Yang Y-J, et al. (2020), Clinical characteristics of coronavirus disease 2019 in patients aged 80 years and older. J Integr Med 18, 5, 395–400. [Google Scholar]
  • Hu K, Guan W-J, Bi Y, et al. (2020) Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial. Phytomedicine, 153242. [CrossRef] [PubMed] [Google Scholar]
  • Runfeng L, Yunlong H, Jicheng H, et al. (2020), Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2). Pharmacol Res 156, 104761. [CrossRef] [PubMed] [Google Scholar]
  • Ru J. 2015. Construction and application of pharmacology database and analysis platform of traditional Chinese medicine system. Northwest A&F University. [Google Scholar]
  • The UniProt Consortium (2012), Reorganizing the protein space at the Universal Protein Resource (UniProt). Nucleic Acids Res 40, D1, D71–75. [CrossRef] [PubMed] [Google Scholar]
  • Szklarczyk D, Gable AL, Lyon D, et al. (2019), STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 47, D1, D607–D613. [CrossRef] [PubMed] [Google Scholar]
  • Huang DW, Sherman BT, Lempicki RA (2009), Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4, 1, 44–57. [CrossRef] [PubMed] [Google Scholar]
  • Rappaport N, Fishilevich S, Nudel R, et al. (2017), Rational confederation of genes and diseases: NGS interpretation via GeneCards, MalaCards and VarElect. Biomed Eng online 16, Suppl 1, 72. [CrossRef] [PubMed] [Google Scholar]
  • Grondin CJ, Davis AP, Wiegers TC, et al. (2018), Accessing an expanded exposure science module at the comparative toxicogenomics database. Environ Health Perspect 126, 1, 014501. [Google Scholar]
  • Li YH, Yu CY, Li X, et al. (2018), Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics. Nucleic Acids Res 46, D1, D1121–D1127. [CrossRef] [PubMed] [Google Scholar]
  • Chen H (2018), VennDiagram: Generate high-resolution Venn and Euler plots (R package version 1.6.20). [Google Scholar]
  • Yang L, Huan G, Qingjun Z, et al. (2017), Research progress on antiviral activity of licorice chemical components. Shandong J Trad Chin Med 36, 2, 167–171. [Google Scholar]
  • Ge H, Wang X, Yuan X, et al. (2020), The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis 39, 6, 1011–1019. [CrossRef] [PubMed] [Google Scholar]
  • Wang W, Ye L, Ye L, et al. (2007), Up-regulation of IL-6 and TNF-alpha induced by SARS-coronavirus spike protein in murine macrophages via NF-kappaB pathway. Virus Res 128, 1–2, 1–8. [CrossRef] [PubMed] [Google Scholar]
  • Chen N, Zhou M, Dong X, et al. (2020), Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lance 395, 10223, 507–513. [Google Scholar]
  • Hsu H-Y, Lin T-Y, Hu C-H, et al. (2018), Fucoidan upregulates TLR4/CHOP-mediated caspase-3 and PARP activation to enhance cisplatin-induced cytotoxicity in human lung cancer cells. Cancer Lett 432, 112–120. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.